BCG immunotherapy of bladder cancer: 20 years on. [Lancet. 1999] - PubMed

loading

Effect of BCG immunotherapy on cell-mediated cytotoxicity in bladder cancer patients following surgical treatment. [Tumori. 1981]
Effect of BCG immunotherapy on cell-mediated cytotoxicity in bladder cancer patients following surgical treatment.
Antonaci S, Piccinno A, Lucivero G, Miglietta A, Piccininno A, Bonomo L. Tumori. 1981 May-Jun; 67(3):177-82.
Review [Immunocompetence and immunotherapy of patients with cancer of the kidney and bladder]. [Urol Nefrol (Mosk). 1986]
Review [Immunocompetence and immunotherapy of patients with cancer of the kidney and bladder].
Mokhort VA, Grigorovich NA, Strotskiĭ AV, Mavrichev AS. Urol Nefrol (Mosk). 1986 Jan-Feb; (1):66-74.
Immunology of bladder cancer. [Minn Med. 1980]
Immunology of bladder cancer.
Mariani AJ, Ritts RE Jr, Rife CC. Minn Med. 1980 Mar; 63(3):173-4.
BCG vaccine in superficial bladder cancer. [BMJ. 1994]
BCG vaccine in superficial bladder cancer.
Sharma N, Prescott S. BMJ. 1994 Mar 26; 308(6932):801-2.
Review [Immunodiagnosis and immunotherapy of bladder tumors]. [Urol Nefrol (Mosk). 1984]
Review [Immunodiagnosis and immunotherapy of bladder tumors].
Kadagidze ZG, Shipilov VI. Urol Nefrol (Mosk). 1984 Jan-Feb; (1):69-72.

Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. [Am J Cancer Res. 2012]
Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model.
Peek EM, Li DR, Zhang H, Kim HP, Zhang B, Garraway IP, Chin AI. Am J Cancer Res. 2012; 2(6):745-51. Epub 2012 Nov 20.
Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder. [Int J Surg Case Rep. 2013]
Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder.
Roylance A, Mosley J, Jameel M, Sylvan A, Walker V. Int J Surg Case Rep. 2013; 4(1):88-90. Epub 2012 Oct 5.
Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A. [PLoS One. 2012]
Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.
Lee SJ, Lee EJ, Kim SK, Jeong P, Cho YH, Yun SJ, Kim S, Kim GY, Choi YH, Cha EJ, et al. PLoS One. 2012; 7(9):e40267. Epub 2012 Sep 4.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

BCG immunotherapy of bladder cancer: 20 years on.
BCG immunotherapy of bladder cancer: 20 years on.
Lancet. 1999 May 15 ;353(9165):1689-94.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed